Company: HCTI
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076686
Chunk: 3

Company: Healthcare Triangle, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
 Conversion of debt to equity 
     -  
     -  
     -  
     -  
     3,008  
     -  
     1,181  
     -  
     1,181 
  
    Stock based compensation 
     -  
     -  
     -  
     -  
     -  
     -  
     51  
     -  
     51 
  
    Balance at June 30, 2024 
     6,000  
    $-  
     -  
    $-  
     22,558  
     -  
    $27,631  
    $(28,277) 
    $(646)

  (1) 117,161 shares of Common Stock that may be issued on full exercise of the pre-funded warrants issued at $0.42 per share.  (2) Up to 4,360,300   shares of Common Stock that may be issued on exercise of the Series B warrants using the “zero exercise price option”.  (3) On June 16, 2025, Healthcare Triangle, Inc. through its wholly owned subsidiary QuantumNexis Inc. (the “Company”) and Niyama Healthcare, Inc., a Delaware corporation, a provider of Mental Health and Hospital Information Systems technology, across India, Southeast Asia, and Europe (the “Seller”) entered into an Asset Transfer Agreement (the “Agreement”). Pursuant to the Agreement, the Company agreed to a total consideration for the acquisition, which is referred to herein as the “Purchase Price” is $5.7 million which includes: (1) $1.5 million in cash, of which $1.2 million is due on the Closing Date and $300,000 to be paid at the later of the satisfaction of certain withholding requirements or within 120 days of the Closing Date; (2) a number of shares of restricted common stock of the Company equal to $3,000,000 divided by $2.17, issued on the Closing Date; and (3) up to $1.2 million in earn-out payments contingent on first-year financial performance targets to be agreed upon within 90 days of the Closing Date. 

The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.

3

HE